Hans Jeppsson
Financieel Directeur/CFO bij VICORE PHARMA HOLDING AB
Vermogen: 8 227 $ op 30-04-2024
Actieve functies van Hans Jeppsson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VICORE PHARMA HOLDING AB | Financieel Directeur/CFO | 01-01-2017 | - |
| Public Communications Contact | 01-01-2017 | - | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - | - |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Directeur/Bestuurslid | - | - |
Loopbaan van Hans Jeppsson
Eerdere bekende functies van Hans Jeppsson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Danske Bank A/S (Sweden) | Analyst-Equity | - | - |
Opleiding van Hans Jeppsson
| University of Gothenburg | Doctorate Degree |
| Handelshögskolan i Göteborg | Doctorate Degree |
Statistieken
Internationaal
| Zweden | 7 |
Operationeel
| Doctorate Degree | 2 |
| Graduate Degree | 2 |
| Analyst-Equity | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VICORE PHARMA HOLDING AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Danske Bank A/S (Sweden) | Finance |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Beurs
- Insiders
- Hans Jeppsson
- Ervaring
